Overview

A Study to Assess the Drug-Drug Interaction Between VX-787 and Oseltamivir

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the drug-drug interaction between VX-787 and oseltamivir, when co-administered at steady-state in healthy participants. In addition the safety, tolerability and pharmacokinetics (the study of the way a drug enters and leaves the blood and tissues over time) of VX-787 will be assessed.
Phase:
Phase 1
Details
Lead Sponsor:
Janssen Infectious Diseases BVBA
Treatments:
Oseltamivir